Bifidobacterium longum BL-10 with Antioxidant Capacity Ameliorates Lipopolysaccharide-Induced Acute Liver Injury in Mice by the Nuclear Factor-κB Pathway
J Dong, L Ping, Y Meng, K Zhang, H Tang… - Journal of Agricultural …, 2022 - ACS Publications
Bifidobacterium longum is frequently utilized and has broad prospects for preventing liver
injury. The current research assessed the antioxidant capacity of B. longum BL-10 and …
injury. The current research assessed the antioxidant capacity of B. longum BL-10 and …
Intestinal microbiomics and hepatic metabolomics insights into the potential mechanisms of probiotic Bifidobacterium pseudolongum CCFM1253 preventing acute …
W Guo, S Cui, X Tang, Y Yan, F Xiong… - Journal of the …, 2023 - Wiley Online Library
BACKGROUND Bifidobacterium pseudolongum is widely exists in mammal gut and its
abundance is associated with human and animal health. The present study aimed to …
abundance is associated with human and animal health. The present study aimed to …
Bifidobacterium bifidum E3 Combined with Bifidobacterium longum subsp. infantis E4 Improves LPS-Induced Intestinal Injury by Inhibiting the TLR4/NF-κB and MAPK Signaling …
Y Yue, Y Wang, Q Xie, X Lv, L Zhou… - Journal of agricultural …, 2023 - ACS Publications
Changes in the functions of the intestinal barrier occur in parallel with the development of
sepsis. The protection by Bifidobacterium strains (BB, BL, BB12, and BLBB) was evaluated …
sepsis. The protection by Bifidobacterium strains (BB, BL, BB12, and BLBB) was evaluated …
Immunomodulatory effects of the Bifidobacterium longum BL-10 on lipopolysaccharide-induced intestinal mucosal immune injury
J Dong, L Ping, T Cao, L Sun, D Liu, S Wang… - Frontiers in …, 2022 - frontiersin.org
The intestine is the largest digestive and immune organ in the human body, with an intact
intestinal mucosal barrier. Bifidobacterium longum is the specific gut commensals colonized …
intestinal mucosal barrier. Bifidobacterium longum is the specific gut commensals colonized …
Bifidobacterium pseudocatenulatum LI09 and Bifidobacterium catenulatum LI10 attenuate D-galactosamine-induced liver injury by modifying the gut microbiota
D Fang, D Shi, L Lv, S Gu, W Wu, Y Chen, J Guo… - Scientific Reports, 2017 - nature.com
The gut microbiota is altered in liver diseases, and several probiotics have been shown to
reduce the degree of liver damage. We hypothesized that oral administration of specific …
reduce the degree of liver damage. We hypothesized that oral administration of specific …
Lactobacillus plantarum KLDS1. 0386 with antioxidant capacity ameliorates the lipopolysaccharide-induced acute liver injury in mice by NF-κB and Nrf2 pathway
J Dong, L Ping, Q Xie, D Liu, L Zhao, SE Evivie… - Food Bioscience, 2022 - Elsevier
The Lactobacillus is of great interest as a natural antioxidant to ameliorate liver injury for its
antioxidant capacity. In a previous experiment, Lactobacillus plantarum KLDS 1.0386 was …
antioxidant capacity. In a previous experiment, Lactobacillus plantarum KLDS 1.0386 was …
In Vitro Probiotic Properties of Bifidobacterium animalis subsp. lactis SF and Its Alleviating Effect on Non-Alcoholic Fatty Liver Disease
H Lv, F Tao, L Peng, S Chen, Z Ren, J Chen, B Yu… - Nutrients, 2023 - mdpi.com
Nonalcoholic fatty liver disease (NAFLD) is a common chronic liver disease with many
influencing factors. With the increasing role of the gut–liver axis in various liver diseases …
influencing factors. With the increasing role of the gut–liver axis in various liver diseases …
Bifidobacterium longum R0175 Protects Rats against d-Galactosamine-Induced Acute Liver Failure
K Wang, L Lv, R Yan, Q Wang, H Jiang, W Wu, Y Li… - Msphere, 2020 - Am Soc Microbiol
Acute liver failure is a severe liver disorder that poses considerable global challenges.
Previous studies on Bifidobacterium longum R0175 have mainly focused on its psychotropic …
Previous studies on Bifidobacterium longum R0175 have mainly focused on its psychotropic …
[HTML][HTML] Bifidobacterium longum subsp. longum K5 alleviates inflammatory response and prevents intestinal barrier injury induced by LPS in vitro based on …
L Zhao, Q Xie, SE Evivie, Y Yue, H Yang, X Lv… - Journal of Functional …, 2022 - Elsevier
Excessive immune responses and intestinal barrier injury are leading causes of
inflammatory bowel diseases (IBD). Previously, we demonstrated that B. longum subsp …
inflammatory bowel diseases (IBD). Previously, we demonstrated that B. longum subsp …
[HTML][HTML] Lactobacillus plantarum and Bifidobacterium longum alleviate liver injury and fibrosis in mice by regulating NF-κB and AMPK signaling
DY Lee, JW Shin, YJ Shin, SW Han… - Journal of Microbiology …, 2024 - ncbi.nlm.nih.gov
In a preliminary study, live biotherapeutic products (LBPs) Lactobacillus plantarum LC27
and Bifidobacterium longum LC67 inhibited the secretion of alanine transaminase (ALT) and …
and Bifidobacterium longum LC67 inhibited the secretion of alanine transaminase (ALT) and …
相关搜索
- antioxidant capacity liver injury
- nf κb liver injury
- antioxidant capacity nf κb
- antioxidant capacity nrf2 pathway
- nrf2 pathway liver injury
- fibrosis in mice liver injury
- ampk signaling liver injury
- barrier function liver injury
- tlr4 nf κb pathways in vivo
- nf κb bifidobacterium bifidum
- pathways in vivo bifidobacterium bifidum
- pathways in vivo intestinal injury
- bifidobacterium bifidum intestinal injury
- bifidobacterium longum immunomodulatory effects
- intestinal microbiomics liver injury
- metabolomics insights liver injury